Research On The Performance Of Blue Sail Medical’s Cross-border Merger And Acquisition Of Biosensors International

Along with our country economy is gradually entering a new era of high quality development,people’s living standards rising,the national health consciousness distinct enhancement,the country’s 14^thFive-Year Plan is put forward to comprehensively promote health,to concentrate advantage resources research key core technology in the field of medical apparatus and instruments,the high-end medical machines,but the domestic medical instrument enterprise is difficult to make up the technology of short board,Both research and development of product innovation and transformation of scientific and technological achievements,have certain gap with foreign advanced technology,the added value of products can get promoted,so in the domestic field of medical devices in the healthcare industry in a weak position in the market,in order to meet the domestic market demand,must raise their technical level for medical devices industry,Acquiring core technologies through mergers and acquisitions to increase market share will be the inevitable trend of the future development of enterprises.Cross-border mergers and acquisitions have become an important way for enterprises to transform and upgrade.By acquiring high-quality overseas companies,enterprises can quickly acquire high-end technologies and world-famous brands,and integrate high-quality resources of target companies to promote the realization of their future development strategies.Among them,Blue Sail Medical Group’s acquisition of Biosensors International is one of the typical cases.Blue Sail Medical was founded in 2002.After nearly 10 years of hard work,Blue Sail Medical continues to expand its scale and achieve rapid development,and has become the largest PVC glove manufacturer in the world.Blue Sail Medical in technology,production and marketing have a certain advantage,but the total operating income and net profit growth,gloves business market capacity is limited,the single product structure,the future development limited,its business has reached the bottleneck,then Blue Sail Medical through cross-border mergers and acquisitions to achieve transformation and upgrading so as to further enhance the profit and development space.Biosensors International is an international well-known heart stents manufacturing vendors,have strong ability of independent research and development,in the global heart stents in the field of medical apparatus and instruments,such as occupy a certain market share,meet Blue Sail Medical development needs,in October 2018 Blue Sail Medical successful m&a Biosensors International entered the field of high-end medical equipment products such as stents,Realized the extension from low value and low consumption to high value and high consumption industry,and expanded the company’s strategic layout.From the perspective of financial performance,the operating ability,debt paying ability,profitability and growth ability of Blue Sail Medical are analyzed.It is found that after the merger,Blue Sail Medical’s debt paying ability is reduced within the scope of risk control,and the other three aspects of capacity are improved.From the perspective of non-financial performance,after the acquisition,Blue Sail Medical’s corporate governance ability and market share of its products have been greatly improved.Based on the market performance,the market reaction after the merger of Blue Sail Medical was analyzed.Shareholders could get excess returns from the merger,and it was found that the merger was successful and improved the performance of the enterprise.The success of Blue Sail Medical’s cross-border merger and acquisition provides experience and inspiration for other similar enterprises to conduct cross-border merger and acquisition.First,enterprises need to keep up with China’s development strategy and actively open up the market.Second,the enterprise should choose the appropriate M&A object scientifically and adopt the appropriate payment method of consideration.Thirdly,enterprises should integrate resources in a timely manner after merger and acquisition to promote the coordinated development of both parties.